Press Release

LabCentral Launches Second Annual LabCentral Ignite Golden Ticket Contest

Offers opportunity for underrepresented biotech entrepreneurs to benefit from LabCentral’s lab space, shared resources and community CAMBRIDGE, Mass., June 21, 2022— LabCentral, with support from Pfizer, Bristol Myers Squibb (BMS) and Mission BioCapital, today announced the launch of its second annual LabCentral Ignite Golden Ticket contest, designed to support diverse, underrepresented biotech entrepreneurs who are […]

LabCentral Launches Second Annual LabCentral Ignite Golden Ticket Contest Read More »

Massachusetts Life Sciences Center announces Mission BioCapital as newest sponsor for initiative to support female entrepreneurs

Mission BioCapital to support female entrepreneurs with a $100K Mission BioCapital Award in the 2022 MassNextGen program round March 28, 2022— Today, the Massachusetts Life Sciences Center (MLSC) announced Mission BioCapital as the newest sponsor for the MLSC’s Massachusetts Next Generation Initiative (MassNextGen), a competitive program for women-led life sciences companies. Mission BioCapital is sponsoring

Massachusetts Life Sciences Center announces Mission BioCapital as newest sponsor for initiative to support female entrepreneurs Read More »

Mission BioCapital Boosts Team to Support Investments From New Fund

CAMBRIDGE, Mass. & SAN FRANCISCO, December 08, 2021— Mission BioCapital, a venture capital firm focused on making investments in early-stage life sciences companies that it uniquely supports as they grow, announced it has made key additions and promotions to its staff after raising its most recent fund, Mission BioCapital V LP. The firm has hired

Mission BioCapital Boosts Team to Support Investments From New Fund Read More »

Mission BioCapital Announces $275 Million Fund V

Record new fund to help biopharma startups achieve pivotal early-stage growth CAMBRIDGE, Mass. & SAN FRANCISCO, November 4, 2021— Mission BioCapital, a venture capital firm focused on making investments in early-stage life sciences companies that it uniquely supports as they grow, announced it has raised $275 million for its next round of investments. Mission BioCapital

Mission BioCapital Announces $275 Million Fund V Read More »